Boostrix Polio (difterie-anatoxine + tetanus-anatoxine + Bordetella pertussis antigenen + poliomyelitisvirus types I, II, III geïnactiveerd suspensie voor injectie (i.m.) (volw. en kind)) · CNK 2374429

Product information

Boostrix Polio
1 dose (0.5 ml)
difterie-anatoxine + tetanus-anatoxine + Bordetella pertussis antigenen + poliomyelitisvirus types I, II, III geïnactiveerd suspensie voor injectie (i.m.) (volw. en kind)
2374429
5.56 / 10
Locked

Product properties

x
J07CA02
GlaxoSmithKline Biologicals
Suspension for injection in pre-filled syringe
BE270435
05050459003195, 05050459006813, 05400571000464
M1
Public
270435-01

Pharmacist Assessment

Structurally fluctuating availability

This product has chronically fluctuating availability (current 5.56/10, historical 🔒/10). Be prepared for possible supply issues and consider keeping an alternative in stock.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 13 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Available again Active
- present
Temporarily unavailable
-

Toegenomen vraag

One or two alternative packsizes available

Composition

9 ingredients

Substance Type Strength CAS
Active ingredient
40 [D'ag'U]
Active ingredient
8 ug/{dose}
Active ingredient
2 [iU]/{dose}
Active ingredient
8 ug/{dose}
Active ingredient
2.5 ug/{dose}
Active ingredient
8 [D'ag'U]
Active ingredient
20 [iU]/{dose}
Active ingredient
32 [D'ag'U]
Excipient

Additional information

Availability statistics

Available again
140 days
4
0
01/04/2026